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GLOBAL HEALTH STRATEGIES 
VERSUS LOCAL PRIMARY HEALTH 
CARE PRIORITIES- A CASE STUDY 
OF NATIONAL IMMUNISATIO N 
DAYS IN SOUTHERN AFRICA 
B Schreuder, C Kostermans 
Building on the successful eraclication of smallpox, the World 
Health Organisation, together with other agencies, is now 
moving quickly to the eradication of poliomyelitis, originally 
aimed for the year 2000. Plans for the subsequent global 
eraclication of measles are in an advanced stage. Eraclication 
of both polio and measles incorporate as a fundamental 
strategy high routine coverage, surveillance and special 
national immunisation days (NlDs), which are supplemen-
tary to routine vaccination services. 
There has been a lively debate on whether poor countries, 
with many health problems that could be controlled, should 
eli vert their limited resouxces for a global goal of eraclication 
that may have low priority for their children. From a cost-
effectiveness perspective, NIDs are fully justifiable. However, 
field observations in sub-saharan Africa show that NIDs 
divert resources and, to a certain extent, attention from the 
development of comprehensive primary health care (PHC). 
The routine immunisation coverage rates dropped on average 
since the introduction of !IDs in 1996, which is contrary to 
what was observed in the western Pacific and other regions. 
The additional investment to be made when moving from 
clisease control to eraclication may exceed the financial 
capacity of an inclividual country. Since the industrialised 
countries benefit most from eraclication, they should take 
responsibility for covering the needs of those countries that 
cannot afford the investment. The WHO's frequent argument 
that NIDs are promotive to PHf": is not confirmed in the 
southern African region. The authors think that the WHO 
should, therefore, focus its attention on diminishing the 
negative side-effects of NIDs and on getting the positive side-
effects incorporated in the integrated health services in a 
sustainable way. 
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In disease control one can distinguish between effective 
control, elimination, global eradication, and extinction. All 
require deliberate efforts. 
Effective control is the reduction of disease incidence, 
prevalence, morbidity or mortality to a locally acceptable level, 
while elimination of disease or infection is the reduction to zero 
of the incidence in a defined geographical area. Both control 
and elimination require continued control measures. 
Global eradication is the reduction to zero of the worldwide 
incidence of infection caused by a specific agent; intervention 
measures are no loner needed . Extinction occurs when the 
specific agent no longer exists in nature or the laboratory. ' 
From an economic point of view, elimination is generally 
considered to be less cost-effective than disease control, since 
the cost per case controlled usually follows the law of 
diminishing returns. Eradication is especially attractive, since 
any specific intervention can be stopped after global 
certification that transmission of infection has ceased. 
Building on the successful eradication of smallpox in 1979, 
the World Health Organisation (WHO), United Nations 
Children's Fund (UNICEF) and other agencies are now moving 
quickly towards the eradication of poliomyelitis, which they 
hope to achieve by the year 2000. Plans for the global 
eradication of measles are in an advanced stage. 
The eradication programmes for polio and measles 
incorporate the following three fundamental strategies: high 
routine coverage, supplemental vaccination (national 
immunisation days (NIDs)) and active surveillance. In 
particular the NIDs have occasioned lively debate, with 
proponents and opponents sometimes taking dogmatic 
positions. 
In the southern African sub-region, the strategy for polio is 
to have 2 annual NIDs 1 month apart in the cold season, 
continuing for up to 3 years. The target group for vaccination is 
all children below the age of 5 years, regardless of their 
vaccination status. With regard to measles, countries have done 
campaigns among children aged between 9 months and 14 
years. Malawi implemented its campaign in September 1998 
and Swaziland and South Africa did mathematical modelling 
to show when the follow-up campaigns must be held. 
On the one hand, proponents of NIDs claim that eradication 
cannot be achieved through routine services alone. They 
demonstrate the enormous savings that can be achieved after 
eradication, owing to the highly favourable cost-effectiveness 
(C/E) ratios. 
On the other hand, opponents claim that the almost military 
vertical approach of NIDs competes with and negatively affects 
comprehensive primary health care (PHC) development. Some 
also fear that eradication strategies are becoming the public 
health strategies for the coming century, diverting funds and 
attention from the continuous care of vulnerable individuals. In 
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their view strengthening routine immunisation services is more 
sustainable. 
This article attempts to bring both parties together by 
considering points of mutual agreement. It has been written 
from personal participation in the firs t rounds of NIDs as well 
as participation in the southern African sub-regional planning 
and evaluation meetings of national Expanded Programme for 
Immunisation (EPI) managers, organised by the WHO/ Africa 
Regional Office (AFRO). Costs and operational aspects of !IDs 
in southern Africa are also analysed in this study. Finally, the 
study includes replies of subscribers to the Afro-Net discussion 
group on NIDs. Replies were to the following questions: 
(i) What are the direct costs (both human and monetary)? 
(ii) Can an individual country afford not to participate in a 
global initiative? (iii) How does an individual poor country 
benefit from NIDs? (iv) What are the negative effects of NIDs 
on sustainability of PHC? (v) Can these effects be minimised? 
THE DILEMMAS O F ERADICATION 
In their article entitled 'Ethical dilemmas in current planning 
for polio eradication', Taylor et af.2 looked at the dilemmas of 
polio eradication at global level. The authors expressed their 
concern at the intensification of worldwide eradication efforts, 
in particular the organisation of NIDs. The authors also raised 
questions regarding the balance between global goals and local 
priorities and the resulting ethical implications. 
Probably the most important question raised by the authors 
is whether poor countries, with many controllable health 
problems, should divert their limited resources towards a 
global goal that has low priority for their children. 
Unfortunately the authors do not provide a clear-cut answer to 
this question. This article attempts to provide such an answer 
for southern Africa. 
What are the costs of NIDs? 
A cost study of NIDs in the southern African WHO sub-region3 
showed that the average direct cost per vaccinated child of two 
rounds of polio vaccine was around US$0.92. This included the 
cost of vaccines, training, logistics, and social mobilisation. 
Vaccines, at 48% of the total, constitu ted the major cost. The 
cost of a single measles vaccination during a campaign, given 
with a disposable syringe that is properly destroyed, is also 
close to US$1. Some savings can be made by giving measles 
and polio vaccines a t the same time, but the different 
operational strategies for polio and measles eradication may 
not alway allow for this. 
The total costs of NIDs in the sub-region have been 
calcula ted. For polio we assumed the maximum scenario of 
three annual campaign of two rounds for all children aged 
under 5 years. For measles we assumed three campaigns: an 
initial campaign for all children aged between 9 months and 14 
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years and two campaigns (for children in the same age group) 
at 4-year intervals thereafter. A 5% additional cost for 
intensifying epidemiological surveillance is included in the 
calculations. Table I shows that the total cost is around US$ 114 
million. 
In both 1996 and 1997 expenditure on !IDs in the region was 
mostly provided by external funds . The exception was South 
Africa, which paid the full amount vvith internal funds. 
Social costs paid by the community to participate in NIDs are 
not included in the above calculations. A costing study in 
Malawi' calculated tha t a mother spends 3 hours and 20 
minutes to bring her child to one round of NIDs. Taking a rural 
salary as US$0.5 per day, the mother's time for two rounds of 
polio adds approximately $0.4 to the direct costs. The hidden 
cost of salaries and operational costs of health care facilities, 
always covered by internal funds, were also excluded from our 
calculations. 
Can countries afford to pay for NIDs? 
Society has to balance expenditure on NIDs with expenditure 
on other pressing needs. In South Africa, NIDs annually 
consume less than 1/ 1 000 of the total recurrent budget for 
health. In contrast, a poor country such as Mozambique with 
an internal health budget of roughly US$30 million per annum 
(US$1.7 per capita), would have to spend US$3 million (or 
10%) of its annual health budget on one national polio 
campaign. With all the goodwill in the world, there is probably 
no country that can suddenly increase its health budget by 
10%. External financial support in the form of loan, credit, or 
grant is therefore indispensable. In practice, such support has 
been forthcoming. 
AffordabiLity of human resources is a potentially more 
serious issue. Vaccination teams usually consist of two to four 
people, at least one of them a professional. In practice, health 
workers are withdrawn from their normal duties for between 2 
days and 2 weeks. As no country has found it difficult to 
recruit basic health workers from the pool of available staff or 
trainees, NIDs have not substantially affected the normal daily 
execution of other PHC services. The time spent by district, 
provincial, and cen tral staff is, however, much more 
substantial. District staff are diverted for 1 - 2 months to plan, 
mobilise, support, train, organise logistics, and evaluate a 
campaign. At provincial level this time may easily double, and 
at central level it may require up to half of the total available 
time of the national EPI manager and his / her staff. 
Consequently, central and provincial s taff can pay much less 
attention to routine services. 
What are the side-effects of NIDs? 
Eradiction stra tegies cannot be seen in isolation- both 
positive and negative side-effects have been extensively 
documented. The proponents of eradication frequently claim 
that experience in the Americas has shown that vaccination 
campaigns can have a positive impact on the development of 
PHC and that social mobilisation reduced distrust between 
health services staff and communities and fostered a new 
awareness of health and prevention.; 
The polio eradication initiative has had a positive impact on 
the quality of epidemiological surveillance systems in most 
countries in the southern African sub-region. By improving 
surveillance of suspected polio {acute flaccid paralysis (AFP)), 
attention was focused on the importance of disease surveillance 
sy terns, which were strengthened accordingly. It is not clear 
whether this improvement will be sustainable once the extra 
resources put in for polio surveillance are withdrawn. Not only 
did the sensitivity of the reporting of cases of suspected polio 
(AFP) increase, but it also contributed to the quality of the 
information system and called attention to the importance of 
epidemiologica l surveillance as such. While it is not yet clear, it 
is hoped that the impact of NID will go further than that of 
the polio initiative alone, and that improvements to 
surveillance will be made in sustainable ways. 
Table I. Estimates of total direct costs (in rnilJjon USS) of NIDs in the South African sub-region 
Population• 
Country {million) % 0-4 yearst Polio % 0- 15 yearst MeasLes Total 
Angola 11.5 18.7 6.23 44.7 .97 15.20 
Botswana 1.5 14.5 0.63 45.7 1.07 1.70 
Lesotho 2.1 17.9 " 1.09 41 .9 1.55 2.64 
Malawi 11.4 19.1 6.31 46.9 9.22 15.53 
Mozambique 15.8 1 .5 8.47 44.5 12.23 20.70 
amibia 1.6 18.6 0.86 44.8 1.25 2.11 
South Africa 37.8 14.5 15.88 38.6 24.34 40.22 
Swaziland 0.9 18.8 0.49 41.9 0.68 1.17 
Zimbabwe 11.5 19.2 6.40 44.5 9.05 15.44 
Total 94.1 17.7 46.37 43.6 68.35 114.71 
'Source: WHO/ EP! Info system, 1996. . 
tSource: Projections from the World Development Report, 1993. 
The NIDs for measles have drawn attention to the need to 
improve injection safety. Many countries have introduced auto-
destruct syringes and needles during campaigns. Countries 
also had to recognise the need to set up a waste disposal 
system, including collection in boxes and proper incineration. 
To date, auto-destruct syringes and needles have m ostly been 
used only during the NIDs, and not for routine vaccinations or 
curative services. Also, it is still not clear if the impact of NIDs 
on injection safety will be sustainable. On the negative side, the 
positiv e impact of campaigns on the coverage rates of routine 
imrnunisations in the western Pacific, as described by Aylward 
eta/} could not be confirmed in the southern African region. 
On the contrary, the coverage rates of the most important 
antigens have, on average, declined since the introduction of 
the NIDs in 1996 (Fig. 1). 
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Source: WHO/AFRO, June 1998 
Fig. 1. Average coverage rates of three antigens in 9 countries of the 
southern African block routine immunisation programmes (1991 -
1997). 
Many countries in sub-Saharan Africa claim that campaigns 
are temporarily disruptive. A South African study' claimed that 
campaigns divert attention from the development of routine 
services. Barron suggested that mass campaigns are only 
acceptable as a catalyst to build PHC services and mobilise 
community awareness of health issues. He concludes that since 
this usually does not happen, campaigns have a negative 
impact on routine services. 
Personal observations in the field and reactions sent by 
e-mail confirm the competitive and disruptive effect of NIDS 
on building sustainable PHC services. So far nobody in 
southern Africa has argued that NIDs support PHC Contrary 
to claims in other parts of the world, NIDs have to some extent 
disrupted the development of integrated PHC structure in the 
southern African region . This is mainly at management level, 
where time spent organising NIDs competes with time spent 
on routine tasks. Participation in !IDs is also usually paid for 
and this may create envy in those who are excluded, causing 
tensions among the s taff. NIDs may also undermine confidence 
in primary level care. As we heard one mother say: 'If we come 
to the facility because we are following the Road-to-Health 
chart, why do we suddenly need extra vaccinations? 
Something must be wrong with the maternal and child health 
services in the health centre.' 
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Opponents of NIDs do not always make the necessary 
distinction between the global goal of eradication and the goal 
of providing daily care to the individual through PHC 
Opponents frequently misconceive NIDs as being an 
alternative way to improve routine coverage figures, and then 
reject NIDs on grounds of inefficiency. 
National perspective versus global responsibilities 
Eradication of a disease is the ultimate goal in terms of 
sustainable impact on that disease. There is no doubt that the 
current global strategies for the eradication of both polio and 
measles can pass the cost-effectiveness (C/ E) tes t with honour 
(see Fig. 2). If the world does not embark on eradication of 
polio and measles, it will face a gradually increasing level of 
costs per disability-adjusted life-year (DALY) gained. The C / E 
ratios for control will, in the final phase, reach unacceptably 
high levels. Against this, C / E ratios for eradication strategies 
become, within the rather short time of less than 10 years of 
concluding the investment, more favourable than those for 
control alone• 
Fig. 2 depicts the cost-effectiveness ratios of control and 
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Fig. 2. Cost-effectiveness ratios for global polio and measles 
eradication and control in a time perspective. 
2030 
The average annual costs per DALY gained by control 
strategies will gradually rise as a resul t of the increasing 
number of children to be vaccinated and the declining number 
of DALYs gained because of the ever-lower transmission rate 
of the disease. The costs per vaccinated child in the control 
strategy will vary greatly by continent, but for reasons of 
simplicity we applied an amount of US$1 as the average cost 
p er vaccinated child in the control scenario for both diseases. 
Costs assume 100% vaccination coverage. 
The average annual costs per DALY gained in an eradication 
strategy are based on the total costs of fhe eradication strate&Y 
divided by the number of DALYs gained since the start of the 
eradication. Total costs of polio eradication are estimated at 
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US$1 billion, and that for measles at US$3.7 billion (UNICEF, 
1997). The average annual costs are the result of the division of 
the total costs by the number of years since the start of 
eradication. A 3% annual discounting has been applied to 
correct for utility in the future. 
It is assumed that for both polio and measles all routine 
vaccinations will be suspended 3 years after global certification 
of a world free of polio or measles. Population projections and 
expected numbers of DALYs gained are projections of the 
trends presented in the Global Burden of Diseases series10 
Bart et al. 11 demonstrated that enormous savings, particularly 
in the industrialised world, would be made after the global 
certification of a world free of polio. The future savings made 
by investing now in eradication efforts are substantial. These 
savings should be used to support the further development of 
integrated PHC, and to compensate for the disruption to these 
services that NIDs are currently provoking. 
Initiatives for global eradication of disease are comparable to 
other global agreements between countries on issues such as 
human rights and the banning of land mines and nuclear 
weapons. Given its great impact, such an agreement should be 
prepared with the greatest possible care and only endorsed if 
the expected contribution of each individual country is defined 
in detail. 
The eradication of polio was endorsed by a 1988 global 
resolution of all member states of the WHO, and was 
co!lfumed at the World Summit for Children in 1990. On both 
occasions the endorsement of polio eradication was based 
solely on technical feasibility and expected future benefits. 
Implications of NIDs on health systems and PHC were not 
considered. 
Since eradication is a global initiative, commitments should 
be shared according to capacity between the 'haves' and 'have-
nets'. As long as there is no consensus regarding their 
importance, eradication initiatives may not recei ve the 
necessary broad support and funding. If the initiative is not 
prioritised by donors it becomes an empty statement, and the 
'have-nots' can only adopt a posture of passive resistance. 
From a monetary point of view the industrialised world 
benefits most from rapid eradication. However the benefits in 
disease reduction are greater in developing countries where the 
incidence of new cases of both polio and measles is higher. 
Taylor eta/.' raise the question of whether poor countries 
with many health problems should divert their limited 
resources towards a global goal that has low priority for their 
own children. By definition, global eradication initiatives need 
the support of all countries of the world; non-participation of a 
single country could jeopardise the entire exercise. 
If an individual country refuses to implement eradication 
interventions it would not be unethical to exercise some 
pressure on that country. If that country, however, suffers from 
constraints in implementation, then committed countries with 
greater resources should be prepared to assist, for example by 
providing vaccines or covering recurrent costs. 
One can question whether .1\.TJDs are an absolute requirement 
for eradicating polio. In fact, NIDs have never been undertaken 
in the USA and Canada. Other countries with high routine 
coverage rates and a reliable surveillance system in place 
(including South Africa) decided not to complete the full set of 
4 years of two rounds of NIDs, relying rather on their 
surveillance system as a prerequisite for the 'Free of polio' 
certification. 
However, the current coverage rates of the routine EPI 
services in some countries in the southern African sub-region 
(Table II) do not provide a solid basis for achieving the target 
for global eradication of polio in a reasonable time period. 
Considering that upgrading the routine EPI services implies a 
major effort, in the short term it is much more cost-effective to 
organise !IDs. The impact of NIDs on disease transmission is 
probably greatest in those countries where routine coverage is 
lowest. As a result of their weak infrastructure, these are 
probably the very countries that will experience most 
disruption from NIDs. To minimise the negative side-effects in 
these countries, IDs must be planned very carefully and well 
in advance. Instead of persisting in pointing out the positive 
impact TIDs have on PHC, the WHO would do better to pay 
more attention to the negative side-effects of Ds. lf PHC has 
to be strengthened, there are more appropria te ways of doing 
so. 
Table II . Coverage rates (% ). of routine vaccination services for 
polio (3rd dose) and measles vaccination (1997) 
Polio Measles 
Angola 36 74 
Botswana 80 79 
Lesotho 57 53 
Malawi 73 87 
Mozambique 61 70 
amibia 65 58 
South Africa 73 76 
Swaziland 73 57 
Zimbabwe 79 73 
African region 57 61 
>$ource: EPI·Wormation System - Immunisation Coverage on Four Antigens, 
WHO, 199 . 
The creation of vertical NlDs structure should not be bluntly 
rejected. It serves a completely different objective to that of 
individual care provided by the integrated routine services. 
Periodic campaigns can never replace the continuous care of 
PH C. 
The discussion should, therefore, not be about whether 
vaccinations should be administered through routine services 
or through NIDs. Society needs integrated PHC, and it needs 
NIDs on a temporary basis to eradicate d isease efficiently. 
• 
Eradication initiatives could contribute to sustainable 
development of the health infrastructure by improving 
epidemiological surveillance systems. This will not only be 
beneficial to the health infrastructure as a whole, but will also 
prevent too many vaccinations being administered, a 
possibility in unreliable surveillance systems. Investing in 
surveillance will quickly pay off. 
Since the Alma Ata conference in 1979, discussions on the 
extent to which target-driven programmes affect sustainable 
PHC have been polarised. The limited health budget has to be 
divided between both eradication programmes and PHC, and 
in that respect they are competitive. During the past 20 years 
target-driven vertical programmes have been separate from 
and have competed with integrated PHC. Each system 
contributes in its own way towards improving health. Both 
systems have a vertical target dimension and a horizontal 
individual care dimension. The vertical dimension is stronger 
in target-driven programmes, the horizontal is stronger in 
PHC. Vertical programmes may have a special place in certain 
phases of the fight against diseases, namely in the beginning to 
start up a programme and at the end to finish the job. To date, 
the world is still divided into horizontalists and verticalists. 
Both groups would do better to sit dovm together and weave 
the horizontal and vertical fibres into a sustainable web. 
The views expressed in this article are those of the authors 
and should not be attributed to their respective organisations. 
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CONTRIBUTION OF GROWTH 
HORMONE-RELEASING HORMONE 
AND SOMATOSTATIN TO 
DECREASED GROWTH HORMONE 
SECRETION IN ELDERLY MEN 
Steven G Soule, Peter Macfarlane, Naomi S Levitt, 
Robert P Millar 
Objective. The pathophysiology of the decline in circulating 
growth hormone (GH) concentrations that may occur with 
ageing remains elusive. We have investigated the potential 
contributions of decreased endogenous GH-releasing 
hormone (GHRH) and increased somatostatin secretion to 
this phenomenon. 
Design and methods. The strategy used was to stimulate GH 
secretion in 8 young (20 - 24 years old, body mass index 
(BMI) 22.8 ± 2.8 kg/m') and 8 elderly (68- 82 years old, 
BMI 23.4 ± 1.6 kg/m') male subjects on separate occasions 
by means of: (1) intravenous bolus 0.5 ).lg/kg D-Aia' 
GHRH(1-29)-NH alone; (it) 0.5 ).lg/kg GHRH after pre-
treatment with two oral doses of 50 mg atenolol (to inhibit 
somatostatin secretion); (iii) 1.25 mg oral bromocriptine 
alone (to increase endogenous GHRH and/or inhibit 
somatostatin); (iv) 50 mg oral atenolol plus 1.25 mg oral 
bromocriptine; and (v) 0.5 ).lg/kg GHRH after pre-treatment 
with 1.25 mg oral bromocriptine. 
Results. The elderly men had a significantly lower peak and 
area under curve (AUC) GH response to intravenous 
GHRH w hen compared with 8 yoll!lg men (peak 3.1 ± 1.0 
ng/ml v. 21.6 ± 5.0 ng/ ml, AUC 205 ±56 ng/ ml/min v. 
1 315 ± 295 ng/ ml / min, P < 0.05). Pre-treatment with 
atenolol before GHRH administration produced no 
significant increase in peak and AUC GH response in both 
groups, whlch remained lower in the elderly men than in 
their young counterparts (peak 5.5 ±"1.8 ng/ ml v. 29.3 ± 7.0 
ng/ml, AUC 327 ± 90 ng/ml/min v. 2 017 ± 590 
ng/ ml/min, P < 0.05). Bromocriptine alone did not cause a 
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